155 related articles for article (PubMed ID: 36095845)
1. Conjunctival Perivascular Epithelioid Cell Neoplasm With RBM10-TFE3 Fusion Presenting as Recurrent Subconjunctival Hemorrhage.
Park KS; Ozzello DJ; Ting M; Fadare O; Liu CY; Kikkawa DO; Korn BS
Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):e15-e17. PubMed ID: 36095845
[TBL] [Abstract][Full Text] [Related]
2. Ocular PEComas are frequently melanotic and TFE3-translocated: report of two cases including the first description of PRCC-TFE3 fusion in PEComa.
Gao Y; Chen G; Chow C; Io I; Wong EWN; Tsui WMS; Lam WY; To KF; Chan JKC; Cheuk W
Virchows Arch; 2021 May; 478(5):1025-1031. PubMed ID: 32676967
[TBL] [Abstract][Full Text] [Related]
3. TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.
Hyrcza MD; Winer DA; Shago M; Au K; Zadeh G; Asa SL; Mete O
Endocr Pathol; 2017 Mar; 28(1):22-26. PubMed ID: 27189222
[TBL] [Abstract][Full Text] [Related]
4. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
5. A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.
Ohe C; Kuroda N; Hes O; Michal M; Vanecek T; Grossmann P; Tanaka Y; Tanaka M; Inui H; Komai Y; Matsuda T; Uemura Y
Med Mol Morphol; 2012 Dec; 45(4):234-7. PubMed ID: 23224603
[TBL] [Abstract][Full Text] [Related]
6. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors.
Maloney N; Giannikou K; Lefferts J; Bridge JA; Linos K
Hum Pathol; 2018 Dec; 82():125-130. PubMed ID: 29626599
[TBL] [Abstract][Full Text] [Related]
7. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
[TBL] [Abstract][Full Text] [Related]
8. NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series.
See SHC; Olivares S; Kulkarni M; Dhillon SK; Fumero-Velazquez MS; Hagstrom MNE; Gerami P
J Cutan Pathol; 2023 Nov; 50(11):956-962. PubMed ID: 37606377
[TBL] [Abstract][Full Text] [Related]
9. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
[TBL] [Abstract][Full Text] [Related]
10. TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.
Chen XF; Yeong J; Chang KTE; Lim AST; Kuick CH; Lim TH; Sudhanshi J; Selvarajan S; Gan VHL; Khor LY
Ann Clin Lab Sci; 2018 Jan; 48(1):110-115. PubMed ID: 29531006
[TBL] [Abstract][Full Text] [Related]
11. Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature.
Saluja K; Thomas J; Zhang S; Sturgis EM; Jain KS; Prieto VG; El-Naggar AK; Bell D
Hum Pathol; 2018 Jun; 76():149-155. PubMed ID: 29208563
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.
Neumann NM; Haffner MC; Argani P; Kao CS; Epstein JI
Am J Surg Pathol; 2021 Feb; 45(2):169-177. PubMed ID: 33002920
[TBL] [Abstract][Full Text] [Related]
13. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.
Tanaka M; Kato K; Gomi K; Matsumoto M; Kudo H; Shinkai M; Ohama Y; Kigasawa H; Tanaka Y
Am J Surg Pathol; 2009 Sep; 33(9):1416-20. PubMed ID: 19606011
[TBL] [Abstract][Full Text] [Related]
14. Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma.
McGregor SM; Alikhan MB; John RA; Kotler H; Bridge JA; Mujacic I; Kadri S; Segal J; Krausz T
Am J Surg Pathol; 2017 May; 41(5):717-722. PubMed ID: 28009605
[TBL] [Abstract][Full Text] [Related]
15. Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.
Liu F; Zhang R; Wang ZY; Xia Q; Shen Q; Shi S; Tu P; Shi Q; Zhou X; Rao Q
Int J Clin Exp Pathol; 2014; 7(9):6409-14. PubMed ID: 25337301
[TBL] [Abstract][Full Text] [Related]
16. Malignant TFE3-rearranged perivascular epithelioid cell neoplasm (PEComa) presenting as a subcutaneous mass.
Shon W; Kim J; Sukov W; Reith J
Br J Dermatol; 2016 Mar; 174(3):617-20. PubMed ID: 26385848
[TBL] [Abstract][Full Text] [Related]
17. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous PEComa does not harbour TFE3 gene fusions: immunohistochemical and molecular study of 17 cases.
Llamas-Velasco M; Mentzel T; Requena L; Palmedo G; Kasten R; Kutzner H
Histopathology; 2013 Jul; 63(1):122-9. PubMed ID: 23711163
[TBL] [Abstract][Full Text] [Related]
19. Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumors.
Szumera-Cieækiewicz A; Kuczkiewicz-Siemion O; Seliga K; Grabowska-Kierył M; Tysarowski A; Wągrodzki M; Świtaj T; Prochorec-Sobieszek M; Rutkowski P
Pol J Pathol; 2019; 70(4):317-322. PubMed ID: 32146802
[TBL] [Abstract][Full Text] [Related]
20. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
